Randomized phase I study of standard-fractionated or accelerated-hyperfractionated radiotherapy with concurrent cisplatin and vindesine for unresectable non-small cell lung cancer: A report of Japan Clinical Oncology Group Study (JCOG 9601)

Satoshi Tsuchiya, Yuichiro Ohe, Takahiko Sugiura, Nobukazu Fuwa, Yoshizumi Kitamoto, Kiyoshi Mori, Hideo Kobayashi, Koichiro Nakata, Toshiyuki Sawa, Kazuya Hirai, Takashi Etoh, Hideo Saka, Atsushi Saito, Haruhiko Fukuda, Naoki Ishizuka, Nagahiro Saijo